AQR Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,903
| Closed | -$2.5M | – | 2342 |
|
|
2021
Q4 | $2.5M | Sell |
26,903
-317
| -1% | -$20.9K | ﹤0.01% | 1054 |
|
|
2021
Q3 | $1.62M | Hold |
27,220
| – | – | ﹤0.01% | 1277 |
|
|
2021
Q2 | $1.86M | Hold |
27,220
| – | – | ﹤0.01% | 1255 |
|
|
2021
Q1 | $1.89M | Sell |
27,220
-6,756
| -20% | -$520K | ﹤0.01% | 1234 |
|
|
2020
Q4 | $2.61M | Buy |
33,976
+1,847
| +6% | +$138K | ﹤0.01% | 1041 |
|
|
2020
Q3 | $2.4M | Buy |
32,129
+596
| +2% | +$39.7K | ﹤0.01% | 1026 |
|
|
2020
Q2 | $1.99M | Sell |
31,533
-3,839
| -11% | -$211K | ﹤0.01% | 1170 |
|
|
2020
Q1 | $1.49M | Sell |
35,372
-16,969
| -32% | -$778K | ﹤0.01% | 1187 |
|
|
2019
Q4 | $2.38M | Sell |
52,341
-8,652
| -14% | -$409K | ﹤0.01% | 1202 |
|
|
2019
Q3 | $2.79M | Buy |
60,993
+6,618
| +12% | +$372K | ﹤0.01% | 1165 |
|
|
2019
Q2 | $3.19M | Buy |
54,375
+1,468
| +3% | +$75.9K | ﹤0.01% | 1118 |
|
|
2019
Q1 | $2.37M | Sell |
52,907
-9,796
| -16% | -$449K | ﹤0.01% | 1250 |
|
|
2018
Q4 | $2.44M | Buy |
62,703
+20,312
| +48% | +$798K | ﹤0.01% | 1182 |
|
|
2018
Q3 | $1.95M | Buy |
42,391
+5,441
| +15% | +$221K | ﹤0.01% | 1406 |
|
|
2018
Q2 | $1.61M | Buy |
36,950
+23,240
| +170% | +$999K | ﹤0.01% | 1525 |
|
|
2018
Q1 | $542K | Buy |
13,710
+2,602
| +23% | +$101K | ﹤0.01% | 1887 |
|
|
2017
Q4 | $377K | Buy |
+11,108
| New | +$316K | ﹤0.01% | 2006 |
|
|
2015
Q3 | – | Sell |
-7,470
| Closed | -$347K | – | 2292 |
|
|
2015
Q2 | $347K | Sell |
7,470
-236
| -3% | -$10.2K | ﹤0.01% | 1923 |
|
|
2015
Q1 | $337K | Sell |
7,706
-4,570
| -37% | -$212K | ﹤0.01% | 1835 |
|
|
2014
Q4 | $426K | Sell |
12,276
-90
| -0.7% | -$3.65K | ﹤0.01% | 2037 |
|
|
2014
Q3 | $518K | Hold |
12,366
| – | – | ﹤0.01% | 1928 |
|
|
2014
Q2 | $725K | Hold |
12,366
| – | – | ﹤0.01% | 1805 |
|
|
2014
Q1 | $779K | Hold |
12,366
| – | – | ﹤0.01% | 1812 |
|
|
2013
Q4 | $723K | Sell |
12,366
-60
| -0.5% | -$3.13K | ﹤0.01% | 1879 |
|
|
2013
Q3 | $655K | Sell |
12,426
-13,106
| -51% | -$880K | ﹤0.01% | 1863 |
|
|
2013
Q2 | $1.97M | Buy |
+25,532
| New | +$2.08M | 0.01% | 1273 |
|
AQR Capital Management's ARNA Position: Q1 2022 in Review
AQR Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 26,903 shares — an estimated $2.5M sold.
AQR Capital Management first reported a position in ARNA in Q2 2013 and held it in 26 quarters. The position peaked at $3.19M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- AQR Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- AQR Capital Management sold 26,903 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.5M.
- AQR Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 26 quarters.
- AQR Capital Management's Arena Pharmaceuticals Inc position peaked at $3.19M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.